Predictive value of muscle relaxant models in rats and cats

Ashton, 1980, Acyl-thioxanthenes: Agents which selectively reduce decerebrate rigidity in the cat, J Med Chem, 23, 653, 10.1021/jm00180a014 Barnett, 1974, The pharmacology of fletazepam, a centrally-acting muscle relaxant, Arch Int Pharmacodyn, 212, 164 Barnett, 1975, Etonitazine-induced rigidity and its antagonism by centrally acting muscle relaxants, Eur J Pharmacol, 30, 23, 10.1016/0014-2999(75)90197-1 Bianchine, 1980, Drugs for Parkinson's disease; centrally acting muscle relaxants, 475 Brown, 1978, Cyclobenzaprine in intractable pain syndromes with muscle spasms, J Amer Med Assoc, 240, 1151, 10.1001/jama.1978.03290110049018 Calne, 1976, The pharmacology of spasticity, Vol 1, 137 DeLee, 1980, Skeletal muscle spasm and a review of muscle relaxants, Curr Ther Res, 27, 64 Domino, 1956, The correlation between animal testing procedures and clinical effectiveness of centrally acting muscle relaxants of the mephenesin type, Ann NY Acad Sci, 64, 705, 10.1111/j.1749-6632.1956.tb36842.x Ellis, 1974, A comparative study of dantrolene sodium and other skeletal muscle relaxants with the Straub tail mouse, Neuropharmacol, 13, 211, 10.1016/0028-3908(74)90109-9 Esplin, 1979, Effects of Cyclobenzaprine on spinal synaptic transmission, Neuropharmacol, 18, 559, 10.1016/0028-3908(79)90101-1 Finney, 1978 Gerstenbrand, 1979, Langzeitbehandlung mit dem imidazolin-dervat DS 102-282, Nervenarzt, 50, 806 Gyory, 1980, The rational use of muscle relaxants in rehabilitation medicine, Drugs, 20, 309, 10.2165/00003495-198020040-00005 Hassan, 1980, Double-blind comparison of single doses of DS 102-282, baclofen and placebo for suppression of spasticity, J Neurol Neurosurg Psychiat, 3, 1132, 10.1136/jnnp.43.12.1132 Hudson, 1970, Central muscle relaxant effect of diazepam, Neuropharmacol, 9, 481, 10.1016/0028-3908(70)90021-3 Kinnard, 1957, A preliminary procedure for the evaluation of central nervous system depressants, J Pharmacol Exp Ther, 121, 354 King, 1954, The action of mephenesin and other interneuron depressants on the brain stem, J Pharmacol Exp Ther, 111, 293 Ludin, 1977, Die Wirkung von DS 103-282, einem neuartigen myotonolytikum, auf die kontraktilen mechanismen in menschlichen skelett muskel, Nervenarzt, 48, 351 Novack, 1982, Studies on the efficacy and depressant potential of muscle relaxants in mice, Drug Develop Res, 2, 383, 10.1002/ddr.430020407 Olpe, 1978, The biological activity d- and l-baclofen (lioresal), Eur J Pharmacol, 52, 133, 10.1016/0014-2999(78)90032-8 Ott, 1978, Statistics: a Tool for the Social Science, 383 1982 Polc, 1974, The effect of diazepam on spinal cord activities: Possible sites and mechanisms of action, Naunyn-Schmiedeberg's Arch Pharmacol, 284, 319, 10.1007/BF00504702 Rackham, 1980, Opiate-induced muscle rigidity in the rat: Effects of centrally acting agents, Neuropharmacol, 19, 855, 10.1016/0028-3908(80)90083-0 Ringwald, 1977, Klinische erfahrungen mit einem neuartigen myotonolytikum (DS 103-282 Sandoz), Nervenarzt, 48, 355 Share, 1975, Cyclobenzaprine: A novel centrally acting muscle relaxant, Neuropharmacol, 14, 675, 10.1016/0028-3908(75)90091-X Slater, 1982, Use of a novel method for investigating muscle relaxant drugs: The effects of clobazam and 1,4 benzodiazepines on morphine-induced rigidity, Drug Develop Res, S1, 153, 10.1002/ddr.430010720 Zbinden, 1967, Pharmacology of benzodiazepines: laboratory and clinical correlations, Adv Pharmacol, 5, 213, 10.1016/S1054-3589(08)60658-4